BiDil, a new tablet containing isosorbide dinitrate and hydralazine for treating heart failure in blacks
August 2005
You'll soon see BiDil, a new tablet containing isosorbide dinitrate and hydralazine for treating heart failure in blacks.
It's the first drug approved for a specific race.
BiDil improves survival when ADDED to standard therapy... ACE inhibitors, beta-blockers, diuretics, etc.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote